Gobet A, Moissonnier L, Zarkadas E, Magnard S, Bettler E, Martin J
Nat Commun. 2025; 16(1):1745.
PMID: 39966360
PMC: 11836358.
DOI: 10.1038/s41467-025-56849-z.
Bollen C, Louwagie S, Deroover F, Duverger W, Khodaparast L, Khodaparast L
Nat Commun. 2025; 16(1):1046.
PMID: 39865082
PMC: 11770139.
DOI: 10.1038/s41467-025-56387-8.
Thomson N, Turner A, Yasir M, Bastkowski S, Lott M, Webber M
Front Antibiot. 2025; 1():957942.
PMID: 39816415
PMC: 11731830.
DOI: 10.3389/frabi.2022.957942.
Alonso-Vasquez T, Giovannini M, Garbini G, Dziurzynski M, Bacci G, Coppini E
Comput Struct Biotechnol J. 2025; 27:1-9.
PMID: 39760074
PMC: 11697298.
DOI: 10.1016/j.csbj.2024.12.002.
Xiang W, Xiong J, Wang H, Cai T, Shi P, Zhao Q
Front Microbiol. 2024; 15:1505841.
PMID: 39678910
PMC: 11638225.
DOI: 10.3389/fmicb.2024.1505841.
Antibiotic-recalcitrant Salmonella during infection.
Giorgio R, Helaine S
Nat Rev Microbiol. 2024; .
PMID: 39558126
DOI: 10.1038/s41579-024-01124-z.
Intracellular ATP concentration is a key regulator of bacterial cell fate.
Li B, Chen X, Yang J, Gao S, Bai F
J Bacteriol. 2024; 206(12):e0020824.
PMID: 39530704
PMC: 11656805.
DOI: 10.1128/jb.00208-24.
Characterization of Persisters from Biofilm Culture: Multiple Dormancy Levels and Multigenerational Memory in Formation.
Ikeda H, Maeda S
Microorganisms. 2024; 12(9).
PMID: 39338564
PMC: 11434456.
DOI: 10.3390/microorganisms12091888.
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.
Russo M, Chen M, Mariella E, Peng H, Rehman S, Sancho E
Nat Rev Cancer. 2024; 24(10):694-717.
PMID: 39223250
DOI: 10.1038/s41568-024-00737-z.
Investigating group A antibiotic tolerance in necrotizing fasciitis.
Keller N, Boumasmoud M, Andreoni F, Tarnutzer A, von Matt M, Scheier T
mSphere. 2024; 9(9):e0063424.
PMID: 39189777
PMC: 11423592.
DOI: 10.1128/msphere.00634-24.
Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance.
Shiraliyev R, Orman M
Elife. 2024; 13.
PMID: 39093940
PMC: 11296704.
DOI: 10.7554/eLife.94903.
Sophisticated natural products as antibiotics.
Lewis K, Lee R, Brotz-Oesterhelt H, Hiller S, Rodnina M, Schneider T
Nature. 2024; 632(8023):39-49.
PMID: 39085542
PMC: 11573432.
DOI: 10.1038/s41586-024-07530-w.
Pheromone cCF10 inhibits the antibiotic persistence of by modulating energy metabolism.
Zhu L, Yang X, Fu X, Yang P, Lin X, Wang F
Front Microbiol. 2024; 15:1408701.
PMID: 39040910
PMC: 11260814.
DOI: 10.3389/fmicb.2024.1408701.
UNRAVELING CRP/cAMP-MEDIATED METABOLIC REGULATION IN PERSISTER CELLS.
Ngo H, Mohiuddin S, Ananda A, Orman M
bioRxiv. 2024; .
PMID: 38915711
PMC: 11195080.
DOI: 10.1101/2024.06.10.598332.
Type I toxin-antitoxin systems in bacteria: from regulation to biological functions.
Shore S, Leinberger F, Fozo E, Berghoff B
EcoSal Plus. 2024; 12(1):eesp00252022.
PMID: 38767346
PMC: 11636113.
DOI: 10.1128/ecosalplus.esp-0025-2022.
Role of 's Buoyant Density in the Development of Biofilm Associated Antibiotic Susceptibility.
Kispert S, Liguori M, Velikaneye C, Qiu C, Wang S, Zhang N
Microorganisms. 2024; 12(4).
PMID: 38674703
PMC: 11052065.
DOI: 10.3390/microorganisms12040759.
Identification of essential genes that support fitness of efflux pump overproducers in the presence of fluoroquinolone.
Hamami E, Huo W, Neal K, Neisewander I, Geisinger E, Isberg R
bioRxiv. 2024; .
PMID: 38260615
PMC: 10802289.
DOI: 10.1101/2024.01.04.574119.
METABOLIC DISRUPTION IMPAIRS RIBOSOMAL PROTEIN LEVELS, RESULTING IN ENHANCED AMINOGLYCOSIDE TOLERANCE.
Shiraliyev R, Orman M
bioRxiv. 2024; .
PMID: 38187583
PMC: 10769322.
DOI: 10.1101/2023.12.20.572673.
Metabolic and transcriptional activities underlie stationary-phase sensitivity to Levofloxacin.
Hare P, Gonzalez J, Quelle R, Wu Y, Mok W
Microbiol Spectr. 2023; 12(1):e0356723.
PMID: 38078717
PMC: 10896071.
DOI: 10.1128/spectrum.03567-23.
Spatial segregation and aging of metabolic processes underlie phenotypic heterogeneity in mycobacteria.
Gwin C, Gupta K, Lu Y, Shao L, Rego E
bioRxiv. 2023; .
PMID: 38076906
PMC: 10705497.
DOI: 10.1101/2023.12.01.569614.